Q00495 (CSF1R_RAT) Reviewed, UniProtKB/Swiss-Prot
Last modified
December 14, 2011.
Version 111.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Macrophage colony-stimulating factor 1 receptor Alternative name(s): CSF-1 receptor Short name=CSF-1-R Short name=CSF-1R Short name=M-CSF-R EC=2.7.10.1 Proto-oncogene c-Fms CD_antigen=CD115 | ||||
| Gene names |
| ||||
| Organism | Rattus norvegicus (Rat) | ||||
| Taxonomic identifier | 10116 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus |
Protein attributes
| Sequence length | 978 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Tyrosine-protein kinase that acts as cell-surface receptor for CSF1 and IL34 and plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of proinflammatory chemokines in response to IL34 and CSF1, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast proliferation and differentiation, the regulation of bone resorption, and is required for normal bone and tooth development. Required for normal male and female fertility, and for normal development of milk ducts and acinar structures in the mammary gland during pregnancy. Promotes reorganization of the actin cytoskeleton, regulates formation of membrane ruffles, cell adhesion and cell migration, and promotes cancer cell invasion. Activates several signaling pathways in response to ligand binding. Phosphorylates PIK3R1, PLCG2, GRB2, SLA2 and CBL. Activation of PLCG2 leads to the production of the cellular signaling molecules diacylglycerol and inositol-1,4,5-trisphosphate, that then lead to the activation of protein kinase C family members, especially PRKCD. Phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leads to activation of the AKT1 signaling pathway. Activated CSF1R also mediates activation of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1, and of the SRC family kinases SRC, FYN and YES1. Activated CSF1R transmits signals both via proteins that directly interact with phosphorylated tyrosine residues in its intracellular domain, or via adapter proteins, such as GRB2. Promotes activation of STAT family members STAT3, STAT5A and/or STAT5B. Promotes tyrosine phosphorylation of SHC1 and INPP5D/SHIP-1. Receptor signaling is down-regulated by protein phosphatases, such as INPP5D/SHIP-1, that dephosphorylate the receptor and its downstream effectors, and by rapid internalization of the activated receptor By similarity. Ref.2 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Enzyme regulation | Present in an inactive conformation in the absence of bound ligand. CSF1 or IL34 binding leads to dimerization and activation by autophosphorylation on tyrosine residues By similarity. |
| Subunit structure | Monomer. Homodimer. Interacts with CSF1 and IL34. Interaction with dimeric CSF1 or IL34 leads to receptor homodimerization. Interacts with INPPL1/SHIP2 and THOC5. Interacts (tyrosine phosphorylated) with PLCG2 (via SH2 domain). Interacts (tyrosine phosphorylated) with PIK3R1 (via SH2 domain). Interacts (tyrosine phosphorylated) with FYN, YES1 and SRC (via SH2 domain). Interacts (tyrosine phosphorylated) with CBL, GRB2 and SLA2 By similarity. |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Note: The autophosphorylated receptor is ubiquitinated and internalized, leading to its degradation By similarity. |
| Domain | The juxtamembrane domain functions as autoinhibitory region. Phosphorylation of tyrosine residues in this region leads to a conformation change and activation of the kinase By similarity. The activation loop plays an important role in the regulation of kinase activity. Phosphorylation of tyrosine residues in this region leads to a conformation change and activation of the kinase By similarity. |
| Post-translational modification | Autophosphorylated in response to CSF1 or IL34 binding. Phosphorylation at Tyr-559 is important for normal down-regulation of signaling by ubiquitination, internalization and degradation. Phosphorylation at Tyr-559 and Tyr-807 is important for interaction with SRC family members, including FYN, YES1 and SRC, and for subsequent activation of these protein kinases. Phosphorylation at Tyr-697 and Tyr-921 is important for interaction with GRB2. Phosphorylation at Tyr-721 is important for interaction with PIK3R1. Phosphorylation at Tyr-721 and Tyr-807 is important for interaction with PLCG2. Phosphorylation at Tyr-974 is important for interaction with CBL By similarity. Ubiquitinated. Becomes rapidly polyubiquitinated after autophosphorylation, leading to its degradation By similarity. |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily. Contains 5 Ig-like C2-type (immunoglobulin-like) domains. Contains 1 protein kinase domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 19 | 19 | By similarity | ||||||||
| Chain | 20 – 978 | 959 | Macrophage colony-stimulating factor 1 receptor | PRO_0000016767 | |||||||
Regions | |||||||||||
| Topological domain | 20 – 515 | 496 | Extracellular Potential | ||||||||
| Transmembrane | 516 – 536 | 21 | Helical; Potential | ||||||||
| Topological domain | 537 – 978 | 442 | Cytoplasmic Potential | ||||||||
| Domain | 24 – 104 | 81 | Ig-like C2-type 1 | ||||||||
| Domain | 107 – 197 | 91 | Ig-like C2-type 2 | ||||||||
| Domain | 204 – 298 | 95 | Ig-like C2-type 3 | ||||||||
| Domain | 299 – 397 | 99 | Ig-like C2-type 4 | ||||||||
| Domain | 398 – 503 | 106 | Ig-like C2-type 5 | ||||||||
| Domain | 580 – 914 | 335 | Protein kinase | ||||||||
| Nucleotide binding | 586 – 594 | 9 | ATP By similarity | ||||||||
| Region | 540 – 572 | 33 | Regulatory juxtamembrane domain By similarity | ||||||||
| Region | 794 – 816 | 23 | Activation loop By similarity | ||||||||
Sites | |||||||||||
| Active site | 776 | 1 | Proton acceptor By similarity | ||||||||
| Binding site | 614 | 1 | ATP By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 544 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||
| Modified residue | 554 | 1 | Phosphotyrosine By similarity | ||||||||
| Modified residue | 559 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||
| Modified residue | 560 | 1 | Phosphothreonine By similarity | ||||||||
| Modified residue | 565 | 1 | Phosphothreonine By similarity | ||||||||
| Modified residue | 697 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||
| Modified residue | 706 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||
| Modified residue | 711 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 714 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 721 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||
| Modified residue | 807 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||
| Modified residue | 921 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||
| Modified residue | 974 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||
| Glycosylation | 45 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 73 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 302 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 335 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 389 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 410 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 449 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 478 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 491 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 42 ↔ 84 | By similarity | |||||||||
| Disulfide bond | 127 ↔ 177 | By similarity | |||||||||
| Disulfide bond | 224 ↔ 278 | By similarity | |||||||||
| Disulfide bond | 417 ↔ 483 | By similarity | |||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Molecular cloning of CSF-1 receptor from rat myoblasts. Sequence analysis and regulation during myogenesis." Borycki A.G., Guillier M., Leibovitch M.P., Leibovitch S.A. Growth Factors 6:209-218(1992) [PubMed: 1389227] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: Wistar. Tissue: Skeletal muscle. |
| [2] | "A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model." Ohno H., Kubo K., Murooka H., Kobayashi Y., Nishitoba T., Shibuya M., Yoneda T., Isoe T. Mol. Cancer Ther. 5:2634-2643(2006) [PubMed: 17121910] [Abstract] Cited for: FUNCTION IN BONE RESORPTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | X61479 mRNA. Translation: CAA43706.1. |
| IPI | IPI00199372. |
| PIR | S16385. I60321. |
| UniGene | Rn.72599. |
3D structure databases | |
| ProteinModelPortal | Q00495. |
| SMR | Q00495. Positions 541-916. |
| ModBase | Search... |
Proteomic databases | |
| PRIDE | Q00495. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Organism-specific databases | |
| RGD | 2425. Csf1r. |
Phylogenomic databases | |
| HOVERGEN | HBG004335. |
Enzyme and pathway databases | |
| BRENDA | 2.7.10.1. 5301. |
Gene expression databases | |
| Genevestigator | Q00495. |
Family and domain databases | |
| InterPro | IPR007110. Ig-like. IPR013783. Ig-like_fold. IPR013098. Ig_I-set. IPR003599. Ig_sub. IPR003598. Ig_sub2. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001245. Ser-Thr/Tyr_kinase. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. IPR016243. Tyr_kinase_CSF1/PDGF_rcpt. IPR001824. Tyr_kinase_rcpt_3_CS. [Graphical view] |
| Gene3D | G3DSA:2.60.40.10. Ig-like_fold. 5 hits. |
| Pfam | PF07679. I-set. 1 hit. PF07714. Pkinase_Tyr. 1 hit. [Graphical view] |
| PIRSF | PIRSF000615. TyrPK_CSF1-R. 1 hit. |
| SMART | SM00409. IG. 3 hits. SM00408. IGc2. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] |
| SUPFAM | SSF56112. Kinase_like. 1 hit. |
| PROSITE | PS50835. IG_LIKE. 4 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. PS00240. RECEPTOR_TYR_KIN_III. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | CSF1R_RAT | ||||||||
| Accession | Primary (citable) accession number: Q00495 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| SIMILARITY comments Index of protein domains and families |

Clusters with